Guided Therapeutics (GTHP) Other Accumulated Expenses (2025 - 2026)

Guided Therapeutics has disclosed Other Accumulated Expenses across 2 years of filings, most recently posting $8000.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses changed N/A year-over-year to $8000.0; the TTM figure through Jun 2026 stood at $8000.0 (changed N/A YoY), while the FY2025 annual figure was $9000.0, changed N/A from the prior year.
• Other Accumulated Expenses came in at $8000.0 for Q2 2026 at Guided Therapeutics, down from $9000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $9000.0 in Q4 2025 to a low of $8000.0 in Q2 2026.